16 cases of non-Hodgkin Lymphoma with Newly Designed Therapy.
10.2185/jjrm.42.77
- VernacularTitle:ｎｏｎ‐Ｈｏｄｇｋｉｎリンパ腫１６例の治療成績
- Author:
Satoko NAKAMURA
;
Tatsuo SHIIGAI
- Publication Type:Journal Article
- Keywords:
non-Hodgkin Lymphoma
- From:Journal of the Japanese Association of Rural Medicine
1993;42(2):77-80
- CountryJapan
- Language:Japanese
-
Abstract:
From July 1989 to May 1992. 16 cases of newly diagnosed non-Hodgkin Lymphoma (NHL) were treated with the following protocols. Patients of 69 years and under were treated with combined (1) CHVP, (2) CHOP, and (3) C-MOPP therapy. Patients of 70years and over were treated with the CHOP therapy.
The remission rate was 87.5%. Two patients relapsed. They were both elderly patients (70>). The relapse rate was 14.3%. The relapse free survival rate was 71.3%. Now 75.2% of the patients of this study survive.
Compared with other protocols, our strategy has been proved to be effective in terms of the remission rate.
